Originally published as Genetics Published Articles Ahead of Print on July 20, 2009.

Genetics, Vol. 183, 347-363, September 2009, Copyright © 2009
doi:10.1534/genetics.109.103952

Additive Genetic Variability and the Bayesian Alphabet

* Department of Animal Sciences, University of Wisconsin, Madison, Wisconsin 53706, {dagger} Department of Animal and Aquacultural Sciences, Norwegian University of Life Sciences, N-1432 Ås, Norway, {ddagger} Institut National de la Recherche Agronomique, UR631 Station d'Amélioration Génétique des Animaux, BP 52627, 32326 Castanet-Tolosan, France, § Institute of Evolutionary Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JT, United Kingdom and ** Department of Animal Science, Iowa State University, Ames, Iowa 50011

1 Corresponding author: Department of Animal Sciences, 1675 Observatory Dr., Madison, WI 53706.
E-mail: gianola{at}ansci.wisc.edu

Manuscript received April 14, 2009. Accepted for publication July 16, 2009.

ABSTRACT

The use of all available molecular markers in statistical models for prediction of quantitative traits has led to what could be termed a genomic-assisted selection paradigm in animal and plant breeding. This article provides a critical review of some theoretical and statistical concepts in the context of genomic-assisted genetic evaluation of animals and crops. First, relationships between the (Bayesian) variance of marker effects in some regression models and additive genetic variance are examined under standard assumptions. Second, the connection between marker genotypes and resemblance between relatives is explored, and linkages between a marker-based model and the infinitesimal model are reviewed. Third, issues associated with the use of Bayesian models for marker-assisted selection, with a focus on the role of the priors, are examined from a theoretical angle. The sensitivity of a Bayesian specification that has been proposed (called "Bayes A") with respect to priors is illustrated with a simulation. Methods that can solve potential shortcomings of some of these Bayesian regression procedures are discussed briefly.


IN an influential article on animal breeding, MEUWISSEN et al. (2001) suggested using all available molecular markers as covariates in linear regression models for prediction of genetic value for quantitative traits. This has led to a genome-enabled selection paradigm. For example, major dairy cattle breeding countries are now genotyping elite animals and genetic evaluations based on SNPs (single nucleotide polymorphisms) are becoming routine (HAYES et al. 2009; VAN RADEN et al. 2009). A similar trend is taking place in poultry (e.g., LONG et al. 2007; GONZÁLEZ-RECIO et al. 2008, 2009), beef cattle (D. J. GARRICK, personal communication), and plants (HEFFNER et al. 2009).

The extraordinary speed with which events are taking place hampers the process of relating new developments to extant theory, as well as the understanding of some of the statistical methods proposed so far. These span from Bayes hierarchical models (e.g., MEUWISSEN et al. 2001) and the Bayesian Lasso (e.g., DE LOS CAMPOS et al. 2009b) to ad hoc procedures (e.g., VAN RADEN 2008). Another issue is how parameters of models for dense markers relate to those of classical models of quantitative genetics.

Many statistical models and approaches have been proposed for marker-assisted selection. These include multiple regression on marker genotypes (LANDE and THOMPSON 1990), best linear unbiased prediction (BLUP) including effects of a single-marker locus (FERNANDO and GROSSMAN 1989), ridge regression (WHITTAKER et al. 2000), Bayesian procedures (MEUWISSEN et al. 2001; GIANOLA et al. 2003; XU 2003; DE LOS CAMPOS et al. 2009b), and semiparametric specifications (GIANOLA et al. 2006a; GIANOLA and DE LOS CAMPOS 2008). In particular, the methods proposed by MEUWISSEN et al. (2001) have captured enormous attention in animal breeding, because of several reasons. First, the procedures cope well with data structures in which the number of markers amply exceeds the number of observations, the so-called "small n, large p" situation. Second, the methods in MEUWISSEN et al. (2001) constitute a logical progression from the standard BLUP widely used in animal breeding to richer specifications, where marker-specific variances are allowed to vary at random over many loci. Third, Bayesian methods have a natural way of taking into account uncertainty about all unknowns in a model (e.g., GIANOLA and FERNANDO 1986) and, when coupled with the power and flexibility of Markov chain Monte Carlo, can be applied to almost any parametric statistical model. In MEUWISSEN et al. (2001) normality assumptions are used together with conjugate prior distributions for variance parameters; this leads to computational representations that are well known and have been widely used in animal breeding (e.g., WANG et al. 1993, 1994). An important question is that of the impact of the prior assumptions made in these Bayesian models on estimates of marker effects and, more importantly, on prediction of future outcomes, which is central in animal and plant breeding.

A second aspect mentioned above is how parameters from these marker-based models relate to those of standard quantitative genetics theory, with either a finite or an infinite number (the infinitesimal model) of loci assumed. The relationships depend on the hypotheses made at the genetic level and some of the formulas presented, e.g., in MEUWISSEN et al. (2001), use linkage equilibrium; however, the reality is that marker-assisted selection relies on the existence of linkage disequilibrium. While a general treatment of linkage disequilibrium is very difficult in the context of models for predicting complex phenotypic traits, it is important to be aware of its potential impact. Another question is the definition of additive genetic variance, according to whether marker effects are assumed fixed or random, with the latter corresponding to the situation in which such effects are viewed as sampled randomly from some hypothetical distribution. MEUWISSEN et al. (2001) employ formulas for eliciting the variance of marker effects, given some knowledge of the additive genetic variance in the population. Their developments begin with the assumption that marker effects are fixed, but these eventually become random without a clear elaboration of why this is so. Since their formulas are used in practice for eliciting priors in the Bayesian treatment (e.g., HAYES et al. 2009), it is essential to understand their ontogeny, especially considering that priors may have an impact on prediction of outcomes.

The objective of this article is to provide a critical review of some of these aspects in the context of genomic-assisted evaluation of quantitative traits. First, relationships between the (Bayesian) variance of marker effects in some regression models and additive genetic variance are examined. Second, connections between marker genotypes and resemblance between relatives are explored. Third, the liaisons between a marker-based model and the infinitesimal model are reviewed. Fourth, and in the context of the quantitative genetics theory discussed in the preceding sections, some statistical issues associated with the use of Bayesian models for (massive) marker-assisted selection are examined, with the main focus on the role of the priors. The sensitivity of some of these methods with respect to priors is illustrated with a simulation.


RELATIONSHIP BETWEEN THE VARIANCE OF MARKER EFFECTS AND ADDITIVE GENETIC VARIANCE

Additive genetic variance:

A simple specification serves to set the stage. The phenotypic value (y) for a quantitative trait is described by the linear model

Formula 1(1)
where a is the additive effect of a biallelic locus on the trait, w is a random indicator variable (covariate) relating a to the phenotype, and E is an independently distributed random deviate, Formula 1, where VE is the environmental or residual variance, provided gene action is additive. Under Hardy–Weinberg (HW) equilibrium, the frequencies of the three possible genotypes are Formula 1, and Formula 1, where Formula 1 and Formula 1. Code arbitrarily the states of w such that

Formula 2(2)
The genetic values of MM, Mm, and mm individuals are a, 0, and –a, respectively. Then

Formula 3(3)

Formula 4(4)
and

Formula 5(5)
This is the variance among genotypes (not among their genetic values) at the locus under HW equilibrium.

A standard treatment (e.g., FALCONER and MACKAY 1996) regards the additive effect a as a fixed parameter. The conditional distribution of phenotypes, given a (but unconditionally with respect to w, since genotypes vary at random according to HW frequencies), has mean

Formula 6(6)
and variance

Formula 7(7)
where VA = 2pqa2 is the additive genetic variance at the locus. In this standard treatment, the additive genetic variance depends on the additive effect a but not on its variance; unless a is assigned a probability distribution, it does not possess variance.

Uncertainty about the additive effect:

Assume now that Formula 7, where {theta} is the mean of the distribution. In the Appendix of MEUWISSEN et al. (2001), a suddenly mutates from fixed to random without explanation. How does the variance of a arise? Parameter Formula 7 can be assigned at least two interpretations. The first one is as the variance between a effects in a conceptual sampling scheme in which such effects are drawn at random from a population of loci. In the second (Bayesian), Formula 7 represents uncertainty about the true but unknown value of the additive effect of the specific locus, but without invoking a scheme of random sampling over a population of loci. For example, Formula 7 = 0 means in a Bayesian sense that a = {theta} with complete certainty, but not necessarily that the locus does not have an effect, since {theta} may (may not) be distinct from 0; this cannot be overemphasized. With a single locus the Bayesian interpretation is more intuitive, since it is hard to envisage a reference population of loci in this case.

Irrespective of the interpretation assigned to Formula 7, the assumption Formula 7 induces another conditional distribution (given w) with mean and variance

Formula 8(8)
and

Formula 9(9)
respectively. However, both w (the genotypes) and a (their effects) are now random variables possessing a joint distribution. Here, it is assumed that w and a are independent, but this may not be so, as in a mutation-stabilizing selection model (e.g., TURELLI 1985) or in situations discussed by ZHANG and HILL (2005) where the distribution of gene frequencies after selection depends on a. Deconditioning over both a and w (that is, averaging over all genotypes at the locus and all values that a can take), the expected value and variance of the marginal distribution of y are

Formula 10(10)
and

Formula 11(11)
This distribution is not normal: the phenotype results from multiplying a discrete random variable w by the normal variate a, and then adding a deviate E, which may or may not be normal, depending on what is assumed about the residual distribution. The genetic variance is now Formula 11. The term Formula 11 stems from randomness (uncertainty) about a, and it dissipates from (11) only if Formula 11 = 0. Note that there is additive genetic variance even if Formula 11 = 0, and it is equal to 2pq{theta}2. Further, if the standard assumption {theta} = 0 is adopted, the variance of the marginal distribution of phenotypes becomes

Formula 12(12)
Here, the standard term for additive genetic variance disappears and yet Formula 12 may not be zero, since one poses that a locus has no effect (on average) but there is some uncertainty or variation among loci effects, as represented by Formula 12.

In a nutshell, the additive genetic variance at the locus, VA = 2pqa2, does not appear in (11), because a has been integrated out; actually, it is replaced by 2pq{theta}2 in (11). The term Formula 12 does not arise in the standard (fixed) model, where additive genetic variance in stricto sensu is VA. When a is known with certainty, then Formula 12 = 0 and yet the locus generates additive genetic variance, as measured by VA = 2pq{theta}2. If {theta} = 0 and Formula 12 = 0, then the variance is purely environmental. In short, the connection between the uncertainty variance Formula 12 and the additive variance VA (which involves the effect of the locus) is elusive when both genotypes and effects are random variables.

Several loci:

Consider now K loci with additive effect ak at locus k, without dominance or epistasis. The phenotype is expressible as

Formula 13(13)
with Formula 13 under HW equilibrium. If all markers were quantitative trait loci (QTL), this would be a "finite number of QTL" model; it is assumed that these loci are markers hereinafter unless stated otherwise. Under this specification

Formula 14(14)
To deduce the additive variance, some assumption must be made about the joint distribution of w1, w2,..., wK, the genotypes at the K loci.

Linkage equilibrium (LE) and HW frequencies are assumed to make the problem tractable. Some expressions are available to accommodate linkage disequilibrium, but parameters are not generally available to evaluate them (see the APPENDIX). When there is selection, genetic drift, or introgression and many loci are considered jointly, some of which will be even physically linked, the LE assumption is unrealistic. Hence, as in the case of many other authors, e.g., BARTON and DE VLADAR (2009) in a study of evolution of traits using statistical mechanics, LE–HW assumptions are used here.

If there is LE, the distributions of genotypes at the K loci are mutually independent, so that

Formula 15(15)
The multilocus additive genetic variance under LE–HW is then Formula 15.

Suppose now that all effects ak Formula 15 are drawn from the same random process with some distribution function Formula 15, mean {theta}, and variance Formula 15. Using the same reasoning as before, the variance of the marginal distribution of the phenotypes is

Formula 16(16)
Then

Formula 17(17)
which generalizes (11) to K loci. The first term is variance due to uncertainty, the second term is the standard additive genetic variance, and the third one is residual variation.

What is the relationship between the multilocus additive genetic variance Formula 17 and Formula 17? Let Formula 17 be the mean variance, obtained by averaging VA over the distribution of the a's. This operation yields

Formula 17
Hence, if {theta} = 0 (additive effects expressed as a deviation from their mean), then

Formula 18(18)
The relationship between the uncertainty variance Formula 18 and the marked average additive genetic variance Formula 18 would then be

Formula 19(19)
in agreement with HABIER et al. (2007), but different from MEUWISSEN et al. (2001). Unless the markers are QTL, Formula 19 gives only the part of the additive genetic variance captured by markers, and this may be a tiny fraction only (MAHER 2008). This makes the connection between additive genetic variance for a trait and marked variance even more elusive.

Corresponding formulas under linkage disequilibrium are in the APPENDIX.

Heterogeneity of variance:

Suppose now that locus effects are independently (but not identically) distributed as Formula 19. The mean of the marginal distribution of phenotypes is Formula 19, and the variance becomes

Formula 19
If all Formula 19 = 0 (complete Bayesian certainty about all marker effects ak), there would still be genetic variance, as measured by the second term in Formula 19. Apart from the difficulty of inferring a given Formula 19 with any reasonable precision, there is the question of possible "commonality" between locus effects. For instance, some loci may have correlated effects, and alternative forms for the prior distribution of the a's have been suggested by GIANOLA et al. (2003). Also, some of these effects are expected to be identically equal to 0, especially if ak represents a marker effect, as opposed to being the result of a QTL [if the marker is in linkage disequilibrium (LD) with the QTL, its effect would be expected to be nonnull]. In such a case, a more flexible prior distribution might be useful, such as a mixture of normals, a double exponential, or a Dirichlet process.

If a frequentist interpretation is adopted for the assumption Formula 19, it is difficult to envisage the conceptual population from which ak is sampled, unless the variances are also random draws from some population. Posing a locus-specific variance is equivalent to assuming that each sire in a sample of Holsteins is drawn from a different conceptual population with sire-specific variance. There would be as many variances as there are sires!

Variation in allelic frequencies:

In addition to assuming random variation of a effects over loci, a distribution of gene frequencies may be posed as well. WRIGHT (1937) found that a beta distribution arose from a diffusion equation that was used to study changes in allele frequencies in finite populations, so this is well grounded in population genetics. In a Bayesian context, on the other hand, assigning a beta distribution to gene frequencies would be a (mathematically convenient) representation of uncertainty.

Suppose that allelic frequencies pk (k = 1, 2,..., K) vary over loci according to the same beta Formula 19 process, where {phi}a, {phi}b are parameters determining the form of the distribution; WRIGHT (1937) expressed these parameters as functions of effective population size and mutation rates. Standard results yield

Formula 20(20)

Formula 21(21)
and

Formula 22(22)
The expected heterozygosity is given by

Formula 23(23)

There are now four sources of variation: (1) due to random sampling of genotypes over individuals in the population, (2) due to uncertainty about additive effects (equivalently, variability due to sampling additive effects over loci), (3) due to spread of gene frequencies over loci or about some equilibrium distribution, and (4) environmental variability. The third source contributes to variance under conceptual repeated sampling, since gene frequencies would fluctuate around the equilibrium distribution or over loci.

Consider now additive genetic variance when dispersion in allelic frequencies is taken into account, assuming LE. Let Formula 23 and Formula 23. Using previous results, (22) and (23),

Formula 24(24)
The expected additive genetic variance is now

Formula 25(25)
To arrive at the marginal distribution of phenotypes, variation in a effects is brought into the picture, producing the variance decomposition

Formula 26(26)
after variation in genotypes and frequencies (i.e., with respect to w and p) has been taken into account. From (13)

Formula 26
so that in the absence of correlations between locus effects

Formula 27(27)
Likewise, using (24),

Formula 28(28)
Combining (27) and (28) as required by (26) leads to

Formula 29(29)

The variance of the marginal distribution of the phenotypes has, thus, three components. The one involving Formula 29 relates to uncertainty about or random variation of marker effects. The second,

Formula 29
is exactly the additive genetic variance when the mean of the distribution of marker effects Formula 29 is known with complete certainty, and the third component is the environmental variance VE. If {theta} = 0 and the first term of (29) is interpreted as additive genetic variance (Formula 29), it turns out that

Formula 30(30)
This is similar to HABIER et al. (2007) only if p0 = q0, {phi}a + {phi}b is large enough, and K is very large, such that

Formula 30
where Formula 30 is the beta density representing variation of allelic frequencies.


RESEMBLANCE BETWEEN RELATIVES

Standard results:

QTL are most often unknown, so their effects and their relationships to those of markers are difficult to model explicitly. An alternative is to focus on effects of markers, whose genotypes are presumably in linkage disequilibrium with one or several QTL, so can be thought of as proxies. Using a slightly different notation, the marker-based linear model suggested by MEUWISSEN et al. (2001) for genomic-assisted prediction of genetic values is

Formula 31(31)
where y is an n x 1 vector of phenotypic values, β is a vector of macroenvironmental nuisance parameters, X is an incidence matrix, Formula 31 is a K x 1 vector of additive effects of markers, and Formula 31 is a known incidence matrix containing codes for marker genotypes, e.g., –1, 0, and 1 for mm, Mm, and MM, respectively. Let the ith row of W be Formula 31 and assume that Formula 31 is a vector of microenvironmental residual effects.

If genotypes are sampled at random from the population, this induces a probability distribution with mean vector

Formula 32(32)
where

Formula 32
and P and Q are matrices whose columns contain pk and qk, respectively, in every position of column k. Every element of the column vector Formula 32 is the same and equal to Formula 32, a constant that can be absorbed into the intercept element of β. Hence, and without loss of generality, Formula 32.

The covariance matrix (regarding β and marker effects am as fixed parameters) is

Formula 32
Here

Formula 32
If genotypes are drawn at random from the same population, all wi vectors have the same distribution, that is, Formula 32 for all i. If the population is in HW–LE, Formula 32 is a diagonal matrix. Further, if individuals are genetically related, off-diagonal terms Formula 32 are not null, because of covariances due to genotypic similarity.

To illustrate, let i be a randomly chosen male mated to a random female, and let j be a randomly chosen descendant. Under HW–LE, genotypes at different marker loci are mutually independent, within and between individuals, so it suffices to consider a single locus. It turns out that

Formula 32
yielding the standard result that the covariance between genotypes of offspring and parent is Formula 32 of the variance between genotypes at the locus in question. This generalizes readily to any type of additive relationships in the population.

Letting rij be the additive relationship between i and j,

Formula 33(33)
where

Formula 34(34)
is the additive genetic variance among multilocus genotypes in HW–LE, and Formula 34 is the matrix of additive relationships between individuals; D is diagonal in this case. The variance–covariance matrix (33) involves the fixed marker effects am, but these get absorbed into VA.

The implication is that a model with the conditional (given marker effects and gene frequencies) expectation function

Formula 35(35)
[recall that Formula 35] and conditional covariance matrix

Formula 36(36)
has the equivalent representation

Formula 37(37)
with Formula 37 distributed as

Formula 38(38)
This is precisely the standard model of quantitative genetics applied to a finite number of marker loci (K), where additive genetic variation stems from the sampling of genotypes but not of their effects. The assumption of normality is not required.

Formulas under LD are given in the second section of the APPENDIX.

Estimating the pedigree-based relationship matrix and expected heterozygosity using markers:

Consider model (37):

Formula 38
Given the observed marker genotypes W, the distribution of W is irrelevant with regard to inference about a*. It is relevant only if one seeks to estimate parameters of the genotypic distribution, e.g., gene frequencies and linkage disequilibrium statistics. Consider, for instance, the expected value of WW':

Formula 38
where Formula 38, and the sum is over markers. If all individuals belong to the same genotypic distribution, as argued above,

Formula 39(39)
as in HABIER et al. (2007); if Formula 39, then Formula 39 so Formula 39. Under this idealized assumption Formula 39 provides an unbiased estimator of the pedigree-based additive relationship matrix, but only if HW–LE holds. Note that under a beta distribution of gene frequencies

Formula 39
Likewise

Formula 39
Using this continuous approximation, (39) becomes

Formula 39
where Formula 39 is the expected heterozygosity. Since the relationship holds for any combination i, j and there are n(n + 1)/2 distinct elements in WW' and in Ar, one can form an estimator of mean heterozygosity as

Formula 39
where Formula 39 and Formula 39 are averages over all distinct elements in WW' and Ar. The estimator is simple, but no claim is made about its properties.


CONNECTION WITH THE INFINITESIMAL MODEL
Clearly, (31) or (37) with (38) involves a finite number of markers, and the marked additive genetic variance is a function of allelic frequencies and of effects of individual markers. In the infinitesimal model, on the other hand, the effects of individual loci or of gene frequencies do not appear explicitly. How do these two types of models connect?

The vector of additive genetic effects (or marked breeding value) of all individuals is Formula 39. Next, assume that effects a1, a2, ... , aK are independently and identically distributed as Formula 39, but this does not need to be so. Again, Formula 39 is not the additive genetic variance, which is given by (34) above.

Assuming Formula 39 implies that a* = Wam must be normal (given W). However, the elements of W (indicators of genotypes, discrete) are also random so the finite sample distribution of a* is not normal; however, as K goes to infinity, the distribution approaches normality, as discussed later in this section. If am and W are independently distributed, the mean vector and covariance matrix of the distribution of marked breeding values are

Formula 40(40)
and

Formula 41(41)
Using the fact that Formula 41 and (33), then under LE assumptions

Formula 41
Since Formula 41, it follows that

Formula 42(42)
This shows that when both genotypes (the w's) and their effects (the a's) vary at random according to independent trinomial (at each locus) and normal distributions, respectively, the variance of the distribution of a marked breeding value a* is affected by differences in gene frequencies pk qk, by the variance of the distribution of marker effects Formula 42, and by the level of heterozygosity. In the special case where allelic frequencies are equal to Formula 42 at each of the loci, the first term vanishes and one gets Formula 42, where Formula 42. This can be construed as the counterpart of the polygenic additive variance of the standard infinitesimal model, but in a special situation. Again, this illustrates that {sigma}a2 relates to additive genetic variance in a more subtle manner than would appear at first sight.

What is the distribution of marked breeding values Formula 42 when both wik and ak vary at random? Because ak is normal, the conditional distribution Formula 42 | wi is normal, with mean 0 and variance Formula 42. Thus, one can write the density of the marginal distribution of Formula 42 as

Formula 42
where Formula 42 is the probability of observing the K-dimensional marker genotype wi in individual i. If the population is in HW–LE at all K marker loci, the joint distribution of genotypes of an individual over the K loci is the product of the marginal distributions at each of the marker loci; that is,

Formula 42
For example, if individual i is AA at locus k, wik1 = 1, wik2 = 0, and wik3 = 0; if i is heterozygote wik1 = 0, wik2 = 1, and wik3 = 0, and if i has genotype aa, then wik1 = 0, wik2 = 0, and wik3 = 1. Note that wik3 = 1 – wik1wik2, so that there are only two free indicator variates. It follows that the marginal distribution of Formula 42 is a mixture of 3K normal distributions each with a null mean, but distribution-specific variance Formula 42. As Formula 42, the mixing probabilities Formula 42 become infinitesimally small, so that

Formula 42
for some density f(w). The mixture distribution of Formula 42 must necessarily converge toward a Gaussian one, because Formula 42 is the sum of a large (now infinite) number of independent random variates (note that under LE wikak is independent of any other wik'ak' because genotypes at different loci are mutually independent), so the central limit theorem holds; it holds even under weaker assumptions. Then

Formula 42
Since all components of the mixture have null means, its variance is just the average of the variances of all components of the mixture (GIANOLA et al. 2006b); that is,

Formula 42
This is the additive genetic variance of an infinitesimal model, i.e., one with an infinite number of loci, so that the probability of any genotypic configuration is infinitesimally small.

When the joint distribution of additive genetic values a* of a set of individuals is considered, it is reasonable to conjecture that it should be multivariate normal, especially under LE. Its mean vector is Formula 42, as shown in (40), and the covariance matrix of the limiting process can be deduced from (42). The first term becomes null, because allelic frequencies became infinitesimally small as Formula 42, so the covariance matrix tends to

Formula 42

As shown by HABIER et al. (2007), markers may act as a proxy for a pedigree. Hence, unless the pedigree is introduced into the model in some explicit form, markers may be capturing relationships among individuals, as opposed to representing flags for QTL regions. At any rate, it is essential to keep in mind that markers are not genes.


THE BAYESIAN ALPHABET
The preceding part of this article sets the quantitative genetics theory basis upon which marker-assisted prediction of breeding value (using linear models) rests. Specifically, MEUWISSEN et al. (2001) use this theory to assess values of hyperparameters of some Bayesian models proposed by these authors. In what follows, a critique of some methods proposed for inference is presented.

Bayes A:

MEUWISSEN et al. (2001) suggested using model (31) for marker-enabled prediction of additive genetic effects and proposed two Bayesian hierarchical structures, termed "Bayes A" and "Bayes B." A brief review of these two methods follows, assuming that k denotes a SNP locus.

In Bayes A (using notation employed here), the prior distribution of a marker effect ak, given some marker-specific uncertainty variance Formula 42, is assumed to be normal with null mean and dispersion Formula 42. In turn, the variance associated with the effect of each marker k = 1, 2,..., K is assigned the same scaled inverse chi-square prior distribution Formula 42, where {nu} and S2 are known degrees of freedom and scale parameters, respectively. This hierarchy is represented as

Formula 42
The marginal prior induced for ak is obtained by integrating the normal density over Formula 42, yielding

Formula 43(43)
(BOX and TIAO 1973; SORENSEN and GIANOLA 2002). This is the kernel of the density of the t-distribution Formula 43, which is the de facto prior in MEUWISSEN et al. (2001) assigned to a marker effect. Again, {upsilon}, S2 are assumed known and given arbitrary values by the user; this is a crucial issue.

Bayes B:

In Bayes B, MEUWISSEN et al. (2001) proposed

Formula 43

Formula 43
This implies that the joint prior distribution of ak and Formula 43, given an arbitrary probability parameter {pi}, is

Formula 43
where c is a constant (if Formula 43, this implies that ak is known with certainty), taken by MEUWISSEN et al. (2001) to be equal to 0, even though it does not need to be 0. Marginally, after integrating Formula 43 out, the prior takes the form

Formula 43
Then, Bayes B reduces to Bayes A by taking {pi} = 0.

A critique:

Neither Bayes A nor Bayes B (or any variations thereof that assume marker-specific variances) allow Bayesian learning on these variances to proceed far away from the prior. This means that the hyperparameters of the prior assigned to these variances (according to assumptions based on quantitative genetics theory) will always have influence on the extent of shrinkage produced on marker effects. A user can arbitrarily control the extent of shrinkage simply by varying {upsilon} and S2. It suffices to illustrate this problem with Bayes A, since the problem propagates to Bayes B.

It is straightforward to show that the fully conditional (i.e., given all other parameters and the data, a situation denoted as ELSE hereinafter) posterior distribution of Formula 43 is the scaled inverse chi-square process Formula 43, so Bayesian learning "moves" only a single degree of freedom away from the prior distribution Formula 43, even though its scale parameter is modified from S2 into Formula 43 (most markers are expected to have nearly null effects). Now, since ak is unknown, and inferring it consumes information contained in the data, this implies that, unconditionally (that is, a posteriori), inferences about Formula 43 are even more strongly affected by the information encoded by its prior distribution than in the conditional posterior process. For instance, if {nu} = 5, say, this means that the posterior degree of belief about Formula 43 has an upper bound at 6, irrespective of whether data on millions of markers or of individuals become available.

For parameter {theta} of a model, Bayesian learning should be such that the posterior coefficient of variation, that is, Formula 43, tends to 0 asymptotically as DATA accrue. This does not happen in Bayes A or Bayes B for Formula 43. In Bayes A, the coefficients of variation of the prior and of the fully conditional posterior distribution are

Formula 43
and

Formula 43
respectively, so that Formula 43. This ratio goes to 1 rapidly as the degrees of freedom of the prior increase (meaning that the prior "dominates" inference), as illustrated in Figure 1. For example, if {nu} = 4.1, {nu} = 5.1, and {nu} = 6.1, the ratio between the coefficients of variation of the conditional posterior distribution of Formula 43 and that of its prior is ~0.30, 0.72, and 0.82, so that the prior is influential even at mild values of the degrees of freedom. Given a large {nu}, the conditional posterior essentially copies the prior, with the contribution of DATA being essentially nil. As mentioned, since marginal posterior inferences about Formula 43 require deconditioning over ak (thus consuming information contained in the data), the impact of the prior will be even more marked at the margins. This is questionable, at least from an inference perspective.


Figure 1
View larger version (6K):
In this window
In a new window
Download PPT slide
 
FIGURE 1.—

Ratio between coefficients of variation Formula 43 of the conditional posterior and prior distributions of the variance of the marker effect, as a function of the degrees of freedom {nu} of the prior.

 
Another way of illustrating the same problem is based on computing information gain, i.e., the difference in entropy before and after observing data. Since the posterior distribution of Formula 43 is unknown, we consider the entropy of the fully conditional posterior distribution of Formula 43, instead of that of the marginal process. This provides an upper bound for the information gain. The entropy of the prior is

Formula 44(44)
In the entropy of the fully conditional posterior distribution of Formula 44, Formula 44, {nu} is replaced by {nu} + 1 and {nu}S2 by Formula 44 (it is expected that Formula 44 {approx} {nu}S2 for most markers). The relative information gain (fraction of entropy reduced by knowledge encoded in ELSE) is then

Formula 45(45)
For instance, RIG = 1 if the entropy of the conditional posterior process is 0. Assume a nil marker effect and a root-scale parameter S = 1. For ak = 0, S = 1, and {nu} = 4, RIG = 0.125; for ak = 0, S = 1, and {nu} = 10, then RIG = 6.51 x 10–2; and for ak = 0, S = 1, and {nu} = 100, RIG = 9.60 x 10–3. Even at mild values of the prior degrees of freedom {nu}, the extent of uncertainty reduction due to observing data is negligible. Metaphorically, the prior is totalitarian in Bayes A, at least for each one of the Formula 45 parameters.

A third gauge is the Kullback–Leibler distance (KL) between the prior and conditional posterior distributions. The KL metric (KULLBACK 1968) is the expected logarithmic divergence between two parametric distributions, one taken as reference or point of departure. Using the prior as reference distribution, the expected distance is

Formula 45
where

Formula 45
is a randomly varying distance (randomness is due to uncertainty about Formula 45, and p is the number of markers that are assigned the same variance, so that p = 1 and am = ak in Bayes A; however, p could be much larger if, say, all p markers on the same chromosome were assigned the same variance.

The impact of the degrees of freedom of the prior on the random quantity L(.) of the integrand in KL was examined by assuming that the conditional posterior distribution of Formula 45 had ak = 0 (again, most marker effects are expected to be tiny, if not null) and that the scale parameter of the prior of the marker-specific variances was S = 1. Figure 2 displays three scaled inverse chi-square densities, all with the same parameter S = 1 and degrees of freedom 4, 10, or 100, as well as values of the random quantity Formula 45 with p = 1 and ak = 0 in the KL gauge. Also shown in Figure 2 (in open circles) are values of Formula 45 for p = 10, meaning that, instead of having marker-specific variances, 10 markers would share the same variance. While the three priors are different, and reflect distinct states of prior uncertainty about Formula 45 via their distinct degrees of freedom, the Formula 45 values are essentially the same irrespective of Formula 45 and flat for any values of Formula 45 appearing with appreciable density in the priors. On the other hand, if it is assumed that Formula 45, where Formula 45 is now a variance assigned to a group of markers (even assuming that their effects are nil), Formula 45 is steep with respect to Formula 45, taking negative values for Formula 45<0.55 (roughly). In fact, the KL distances (evaluated with numerical integration) between the prior and conditional posterior distributions are (1) 7.33 x 10–2 for {nu} = 4, S = 1, p = 1 and ak = 0; (2) 2.64 x 10–2 for {nu} = 10, S = 1, p = 1 and ak = 0; and (3) 2.52 x 10–3 for {nu} = 100, S = 1, p = 1, and ak = 0, so that the conditional posterior is very close to the prior even at small values of the degrees of freedom parameter. However, when the number of markers sharing the same variance increases to p = 10 (assuming all Formula 45's = 0, as stated), KL = 4.47, so that considerable Bayesian learning about Formula 45 takes place in this situation. Relative to scenario 1 above, the KL distance increases by ~61 times.


Figure 2
View larger version (15K):
In this window
In a new window
Download PPT slide
 
FIGURE 2.—

Prior densities of the marker-specific variance Formula 45 (solid circles, {nu} = 4, S = 1; solid curve, {nu} = 10, S = 1; crosses, {nu} = 100, S = 1) and values of integrand Formula 45 in the Kullback–Leibler distance, for each of the three priors, shown as solid lines. The integrands are essentially indistinguishable from each other for all values of Formula 45. Values of the integrand are drastically different (open circles) when 10 markers are assigned the same variance, so that Formula 45.

 
A pertinent question is whether or not the learned marker effect (i.e., a draw from its conditional posterior distribution) has an important impact on KL via modification of the scale parameter from S2 into Formula 45. Let Formula 45 be the realized value of the marker effect in units of the "prior standard deviation" S, with c = 0, 0.01, 0.5, 1, and 2; the last two cases would be representative of markers with huge effects. The density of the conditional posterior distribution of Formula 45 is then

Formula 45
The KL distances between the conditional posterior and the prior for these five situations, assuming S = 1 and {nu} = 4, are (1) Formula 45, (2) KLFormula 45, (3) KLFormula 45, (4) KLFormula 45, and (5) KLFormula 45. Even though marker effects are drastically different, the conditional posteriors are not too different (in the KL sense) from each other, meaning that the extent of shrinkage in Bayes A (or B) continues to be dominated by the prior. This is illustrated in Figure 3: even when c = 2, the conditional posterior does not differ appreciably from the prior.


Figure 3
View larger version (15K):
In this window
In a new window
Download PPT slide
 
FIGURE 3.—

Effect of scale parameter on the conditional posterior distribution of the variance of the marker effect. Open boxes, prior distribution; solid circles, conditional posterior distribution for c = 2 (standardized marker effect). The other three conditional distributions (solid lines) are barely distinguishable from the prior.

 
In short, neither Bayes A nor Bayes B, as formulated by MEUWISSEN et al. (2001), allows for any appreciable Bayesian learning about marker-specific variances so that, essentially, the extent of shrinkage of effects will always be dictated strongly by the prior, which negates the objective of introducing marker-specific variances into the model. The magnitudes of the estimates of marker effects can be made smaller or larger at will via changes of the degrees of freedom and scale parameters of the prior distribution.

Arguably, Bayes B is not well formulated in a Bayesian context. MEUWISSEN et al. (2001) interpret that assigning a priori a value Formula 45 with probability {pi} means that the specific SNP does not have an effect on the trait. As mentioned earlier in this article, stating that a parameter has 0 variance a priori does not necessarily mean that the parameter takes value 0: it could have any value, but known with certainty. Thus, assuming Formula 45 implies determinism about such an effect. It turns out, however, that their sampler sets ak = 0 when the state Formula 45 is drawn! A more reasonable specification is to place the mixture with a 0 state at the level of the effects, but not at the level of the variances.

Impact on predictions:

A counterargument to the preceding critique could be articulated as follows: Even though the prior affects inferences about marker-specific variances, this is practically irrelevant, because one can "kill" the influence of the prior on estimates of marker effects simply by increasing sample size. Superficially, it seems valid, because the fully conditional posterior distribution of ak (assuming a model with a single location parameter µ) is

Formula 45
As sample size n increases, Formula 45 tends to Formula 45 so the influence of Formula 45 vanishes asymptotically, given some fixed values of {nu}, S. This indicates that, in Bayes A, even though Bayesian learning about the Formula 45 parameters is limited, the influence of the prior on the posterior distributions of marker effects and of the genetic values Formula 45 dissipates in large samples. However, in marker-assisted prediction of genetic values n < < p, so the prior may be influential. The sensitivity of Bayes A with respect to the prior in a finite sample was examined by simulation.

Simulation:

Bayes A was fitted under different prior specifications to a simple data structure. Records for 300 individuals were generated under the additive model

Formula 45
where yi is the phenotype for individual i, and the rest is as before. Residuals were independently sampled from a standard normal distribution.

Two LD scenarios regarding the distribution of the 280 markers were generated. In scenario X0, markers were in weak LD, with almost no correlation between genotypes of adjacent markers (Table 1). In scenario X1, LD was relatively high: the correlation between markers dropped from 0.772 for adjacent markers to 0.354 for markers separated by three positions (Table 1). Effects of allele substitutions were kept constant across simulations and were set to zero for all markers except for 10, as shown in Figure 4. The locations of markers with nonnull effects were chosen such that different situations were represented. For example (Figure 4), in chromosome 3 there were two adjacent markers with opposite effects, while chromosome 4 had two adjacent markers with equal effects.


View this table:
In this window
In a new window

 
TABLE 1

Correlation between marker genotypes (average over markers and over 100 Monte Carlo replicates) by scenarios of adjacency between pairs of markers and of linkage disequilibrium (X0, low linkage disequilibrium; X1, high linkage disequilibrium)

 

Figure 4
View larger version (12K):
In this window
In a new window
Download PPT slide
 
FIGURE 4.—

Positions (chromosome and marker number) and effects of markers (there were 280 markers, with 270 having no effect).

 
A Monte Carlo study with 100 replicates was run for each of the two LD scenarios. For each replicate and LD scenario, nine variations of Bayes A were fitted, each defined by a combination of prior values of hyperparameters. In all cases, a scale inverted chi-square distribution with 1 d.f. and scale parameter equal to 1 were assigned to the residual variance. The nine priors considered are in Table 2. Hyperparameter values were chosen such that the prior had, at most, the same contribution to the degrees of freedom of the fully conditional distribution as the information coming from the remaining components of the model (i.e., 1). Values of S2 were chosen following similar considerations. Note that if the samples of marker effects are equal to their true value, Formula 45 ≤ 0.22 (see Figure 4). Priors 1–3 are improper, and the other six priors are proper but do not possess finite means and variances. Therefore, scenarios with S2 = 10–5 correspond to cases of relatively small influence of the prior on the scale parameter of the fully conditional distribution, while S2 = 5 x 102 represents a case where the fully conditional distribution has a strong dependency on the prior specification.


View this table:
In this window
In a new window

 
TABLE 2

Nine different specifications of hyperparameters of the prior distribution of marker variances in Bayes A ({nu}, prior degrees of freedom; S2, prior scale parameter)

 
For each of these models and Monte Carlo replicates 35,000 iterations of the Gibbs Sampler were run, and the first 5000 iterations were discarded as burn-in. Inspection of trace plots and other diagnostics (effective sample size, MC standard error) computed using Coda (PLUMMER et al. 2008) indicated that this was adequate to infer quantities of interest.

Table 3 shows the average (across 100 MC replicates) of posterior means of the residual variance and of the correlation between the true and the estimated quantity of several features. This provides an assessment of goodness of fit, of how well the model estimates genomic values, and of the extent to which the model can uncover relevant marker effects. As expected, Bayes A was sensitive with respect to prior specification for all items monitored. Scenarios 4 and 7 produced overfitting (low estimate of residual variance, whose true value was 1, and high correlation between data and fitted values). It also had a low ability to recover signal (i.e., to estimate marker effects and genomic values), as indicated by the corresponding correlations. Other priors (e.g., 6) produced a model with a better ability to estimate genomic values and marker effects. These results were similar in both scenarios of LD. The results in Table 3 also indicate that it is much more difficult to uncover marker effects than to predict genomic values.


View this table:
In this window
In a new window

 
TABLE 3

Average (over 100 replicates) of posterior mean estimates of residual variance ({sigma}2) and of the correlation between the true and the estimated value for several items (phenotypes, y; true genomic value, Wam; fitted genomic value, Formula 45; true marker effects, am; estimated marker effects,

 
To have a measure of the ability of each model to locate genomic regions affecting the trait, an index was created as follows. For each marker having a nonnull effect and for each replicate, a dummy variable was created indicating whether or not the marker, or any of its 4 flanking markers, ranked among the top 20 on the basis of the absolute value of the posterior mean of the marker's effect. Averaging across markers and replicates led to an index of "retrieved regions" (Table 4). Results suggest that the ability of Bayes A to uncover relevant genomic regions is also affected by the choice of hyperparameters. For example, in scenarios 1, 4, and 7 only one of five regions was retrieved by Bayes A. On the other hand, the fraction of retrieved regions was twice as large when using other priors (scenarios 2, 3, and 6). The ability to uncover genomic regions affecting a trait was usually worse with high LD, due to redundancy between markers.


View this table:
In this window
In a new window

 
TABLE 4

Fraction of retrieved regions by set of priors in Bayes A and scenario of linkage disequilibrium (LD)

 


DISCUSSION
This article examined two main issues associated with the development of statistical models for genome-assisted prediction of quantitative traits using dense panels of markers, such as single-nucleotide polymorphisms. The first one is the relationship between parameters from standard quantitative genetics theory, such as additive genetic variance, and those from marker-based models, i.e., the variance of marker effects. In a Bayesian context, the latter act mainly as a measure of uncertainty. It was shown that the connection between the variance of marker effects and the additive genetic variance depends on what is assumed about locus effects. For instance, in the classical model of FALCONER and MACKAY (1996), locus effects are considered as fixed and additive genetic variance stems from random sampling of genotypes. To introduce a variance of marker effects, these must be assumed to be random samples from some distribution that, in the Bayesian setting, is precisely an uncertainty distribution. The article also discussed assumptions that need to be made to establish a connection between the two sets of parameters and introduced a more general partition of variance, in which genotypes, effects, and allelic frequencies are random variables. Some expressions for relating additive genetic variance and that of marker effects are available under the assumption of linkage equilibrium, as discussed in the article. However, accommodating linkage disequilibrium explicitly into an inferential system suitable for marker-assisted selection represents a formidable challenge.

The second aspect addressed in this study was a critique of methods Bayes A and B as proposed by MEUWISSEN et al. (2001). These methods require specifying hyperparameters that are elicited using formulas related to those mentioned in the paragraph above; however, the authors did not state the assumptions needed precisely. It was shown here that these hyperparameters can be influential.

The influence of the prior on inferences and predictions via Bayes A can be mitigated in several ways. One way consists of forming clusters of markers such that their effects share the same variance. Thus, shrinkage would be specific to the set of markers entering into the cluster. The clusters could be formed either on the basis of biological information (e.g., according to coding or noncoding regions specific to a given chromosome) or perhaps statistically, using some form of supervised or unsupervised clustering procedure. If clusters of size p were formed, the conditional posterior distribution of the variances of the markers would have p + {nu} d.f., instead of 1 + {nu} in Bayes A. A second way of mitigating the impact of hyperparameters is to assign a noninformative prior to the scale and degrees of freedom parameters of Bayes A. This has been done in quantitative genetics, as demonstrated by STRANDÉN and GIANOLA (1998) and ROSA et al. (2003, 2004) and discussed in SORENSEN and GIANOLA (2002). For example, STRANDÉN and GIANOLA (1998) used models with t-distributions for the residuals (the implementation would be similar in Bayes A, with the t-distribution assigned to marker effects instead), with unknown degrees of freedom and unknown parameters. In STRANDÉN and GIANOLA (1998) a scaled inverted chi-square distribution was assigned to the scale parameter of the t-distribution, and equal prior probabilities were assigned to a set of mutually exclusive and exhaustive values of the degrees of freedom. On the other hand, ROSA et al. (2003, 2004) presented a more general treatment, in which the degrees of freedom were sampled with a Metropolis–Hastings algorithm. A third modification of Bayes A would consist of combining the two preceding options, i.e., assign a common variance to a cluster of marker effects and then use noninformative priors, as in ROSA et al. (2003, 2004), for the parameters of the t-distribution. Applications of thick-tailed priors, such as the t or the double exponential distribution, to models with marker effects are presented in YI and XU (2008) and DE LOS CAMPOS et al. (2009a).

Bayes B requires a reformulation (and a new letter, to avoid confusion!), e.g., the mixture with a zero state posed at the level of effects and not at that of the variances, as discussed earlier. For example, one could assume that the marker effect is 0 with probability {pi} or that it follows a normal distribution with common variance otherwise. Further, the mixing probability {pi} could be assigned a prior distribution, e.g., a beta process, as opposed to specifying an arbitrary value for {pi}. Mixture models in genetics are discussed, for example, by GIANOLA et al. (2006b) and some new, yet unpublished, normal mixtures for marker-assisted selection are being developed by R. L. Fernando (R. L. FERNANDO, unpublished data) (http://dysci.wisc.edu.edu/sglpe/pdf/Fernando.pdf).

A more general solution is to use a nonparametric method, as suggested by GIANOLA et al. (2006a), GIANOLA and VAN KAAM (2008), GIANOLA and DE LOS CAMPOS (2008) and casted more generally by DE LOS CAMPOS et al. (2009a). These methods do not make hypotheses about mode of inheritance, contrary to the parametric methods discussed above, where additive action is assumed. Evidence is beginning to emerge that nonparametric methods may have better predictive ability when applied to real data (GONZÁLEZ-RECIO et al. 2008, 2009; N. LONG, D. GIANOLA, G. J. M. ROSA and K. A. WEIGEL, unpublished results.).

In conclusion, this article discussed connections between marker-based additive models and standard models of quantitative genetics. It was argued that the relationship between the variance of marker effects and the additive genetic variance is not as simple as has been reported, becoming especially cryptic if the assumption of linkage equilibrium is violated, which is manifestly the case with dense whole-genome markers. Also, a critique of earlier models for genomic-assisted evaluation in animal breeding was advanced, from a Bayesian perspective, and some possible remedies of such models were suggested.


APPENDIX

Linkage disequilibrium:

The expression Formula 45 results from jointly sampling genotypes (but not their effects) at K loci in linkage equilibrium. This is a needed assumption for arriving at (19). On the other hand, if there is LD, the additive genetic variance (under HW equilibrium at each locus) is

Formula A1(A1)
where Formula A1pB,l is the usual LD statistic involving the two loci in question. The first term in (A1) is the additive genetic variance under LE; the second term is a contribution to variance from LD, and it may be negative or positive. It can be shown that the average correlation between genotypes at a pair of loci is (approximately) <K–1.

The average (over a effects) variance under LD depends on the distribution of the a's. If these are independently and identically distributed with mean {theta} and variance Formula A1, one has

Formula A2(A2)
If {theta} = 0, then Formula A2(D) = Formula A2, in which case linkage disequilibrium would not affect relationship (19).

There is no mechanistic basis for expecting that all loci have the same effects and for these being mutually independent. There may be some genomic regions without any effect at all, or some regions may induce similarity (or dissimilarity) of effects; for example, if two genes are responsible for producing a fixed amount of transcript, their effects would be negatively correlated, irrespective of whether or not genotypes are in linkage equilibrium. A more general assumption may be warranted, i.e., that effects follow some multivariate distribution Formula A2, where Formula A2 is just a dispersion parameter. Here, with w being the vector of genotypes for the K loci, one can write the average variance under LD,

Formula A2
where M is the covariance matrix of w (diagonal under LE),

Formula A2
Further,

Formula A2
where Formula A2 is the trace of the matrix in question. The counterpart of (19) is

Formula A3(A3)
which is a complex relationship even if {theta} = 0. It follows that (19), appearing often in the literature, holds only under strong simplifying assumptions. In short, the connection between additive genetic variance and the variance of marker effects depends on the unknown means of the distributions of marker effects, their possible covariances (induced by unknown molecular and chromosomal process), their gene frequencies, and all pairwise linkage disequilibrium parameters, which are a function of the Formula A3's. It is not obvious what the effects of using (19) as an approximation are, but the assumptions surrounding it are undoubtedly strong.

Covariance between relatives and linkage disequilibrium:

Linkage disequilibrium complicates matters, as noted earlier. The covariance between marked genetic values of individuals i and j, instead of being Formula A3, takes the form

Formula A3
and M* is no longer a diagonal matrix, because of LD creating covariances between genotypes at different marker loci. The diagonal elements of M* have the form (assuming HW frequencies within each locus)

Formula A3
and the off-diagonals are

Formula A3
This implies that disequilibrium statistics D must be brought into the picture when estimating a pedigree relationship matrix using markers in LD.


ACKNOWLEDGEMENTS
Hugo Naya, Institut Pasteur of Uruguay is thanked for having engineered the two linkage disequilibrium scenarios used in the simulation. The Associate Editor is thanked for his careful reading of the manuscript and for help in clarifying some sections of the article. Part of this work was carried out while D. Gianola was a Visiting Professor at Georg-August-Universität, Göttingen, Germany (Alexander von Humboldt Foundation Senior Researcher Award), and a Visiting Scientist at the Station d'Amélioration Génétique des Animaux, Centre de Recherche de Toulouse, France (Chaire D'Excellence Pierre de Fermat, Agence Innovation, Midi-Pyreneés). Support by the Wisconsin Agriculture Experiment Station and by National Science Foundation (NSF) grant Division of Mathematical Sciences NSF DMS-044371 to D.G. and G. de los C. is acknowledged.


LITERATURE CITED

BARTON, N. H., and H. P. DE VLADAR, 2009 Statistical mechanics and the evolution of polygenic quantitative traits. Genetics 181: 997–1011.[Abstract/Free Full Text]

BOX, G. E. P., and G. C. TIAO, 1973 Bayesian Inference in Statistical Analysis. Addison-Wesley, Reading, MA.

DE LOS CAMPOS, G., D. GIANOLA and G. J. M. ROSA, 2009a Reproducing kernel Hilbert spaces regression: a general framework for genetic evaluation. J. Anim. Sci. 87: 1883–1887.[Abstract/Free Full Text]

DE LOS CAMPOS, G., H. NAYA, D. GIANOLA, J. CROSSA, A. LEGARRA et al., 2009b Predicting quantitative traits with regression models for dense molecular markers and pedigrees. Genetics 182: 375–385.[Abstract/Free Full Text]

FALCONER, D. S., and T. F. C. MACKAY, 1996 Introduction to Quantitative Genetics, Ed. 4. Longmans Green, Harlow, Essex, UK.

FERNANDO, R. L., and M. GROSSMAN, 1989 Marker-assisted selection using best linear unbiased prediction. Genet. Sel. Evol. 33: 209–229.[CrossRef]

GIANOLA, D., and G. DE LOS CAMPOS, 2008 Inferring genetic values for quantitative traits non-parametrically. Genet. Res. 90: 525–540.[CrossRef][Medline]

GIANOLA, D., and R. L. FERNANDO, 1986 Bayesian methods in animal breeding. J. Anim. Sci. 63: 217–244.[Abstract/Free Full Text]

GIANOLA, D., M. PÉREZ-ENCISO and M. A. TORO, 2003 On marker-assisted prediction of genetic value: beyond the ridge. Genetics 163: 347–365.[Abstract/Free Full Text]

GIANOLA, D., R. L. FERNANDO and A. STELLA, 2006a Genomic assisted prediction of genetic value with semi-parametric procedures. Genetics 173: 1761–1776.[Abstract/Free Full Text]

GIANOLA, D., B. HERINGSTAD and J. ØDEGÅRD, 2006b On the quantitative genetics of mixture characters. Genetics 173: 2247–2255.[Abstract/Free Full Text]

GIANOLA, D., and J. B. C. H. M. VAN KAAM, 2008 Reproducing kernel Hilbert spaces methods for genomic assisted prediction of quantitative traits. Genetics 178: 2289–2303.[Abstract/Free Full Text]

GONZÁLEZ-RECIO, O., D. GIANOLA, N. LONG, K. A. WEIGEL, G. J. M. ROSA et al., 2008 Nonparametric methods for incorporating genomic information into genetic evaluations: an application to mortality in broilers. Genetics 178: 2305–2313.[Abstract/Free Full Text]

GONZÁLEZ-RECIO, O., D. GIANOLA, G. J. M. ROSA, K. A. WEIGEL and A. KRANIS, 2009 Genome-assisted prediction of a quantitative trait in parents and progeny: application to food conversion rate in chickens. Genet. Sel. Evol. 41: 3–13.[CrossRef][Medline]

HABIER, D., R. L. FERNANDO and J. C. M. DEKKERS, 2007 The impact of genetic relationship information on genome-assisted breeding values. Genetics 177: 2389–2397.[Abstract/Free Full Text]

HAYES, B. J., P. J. BOWMAN, A. J. CHAMBERLAIN and M. E. GODDARD, 2009 Invited review: genomic selection in dairy cattle: progress and challenges. J. Dairy Sci. 92: 433–443.[CrossRef][Medline]

HEFFNER, E. L., M. E. SORRELL and J. L. JANNINK, 2009 Genomic selection for crop improvement. Crop Sci. 49: 1–12.[CrossRef]

KULLBACK, S., 1968 Information Theory and Statistics, Ed. 2. Dover, New York.

LANDE, R., and R. THOMPSON, 1990 Efficiency of marker-assisted selection in the improvement of quantitative traits. Genetics 124: 743–756.[Abstract]

LONG, N., D. GIANOLA, G. J. M. ROSA, K. A. WEIGEL and S. AVENDAÑO, 2007 Machine learning classification procedure for selecting SNPs in genomic selection: application to early mortality in broilers. J. Anim. Breed. Genet. 124: 377–389.[Medline]

MAHER, B., 2008 The case of the missing heritability. Nature 456: 18–21.[Medline]

MEUWISSEN, T. H., B. J. HAYES and M. E. GODDARD, 2001 Prediction of total genetic value using genome-wide dense marker maps. Genetics 157: 1819–1829.[Abstract/Free Full Text]

PLUMMER, M., N. BEST, K. COWLES and K. VINES, 2008 Coda: output analysis and diagnostics for MCMC. http://cran.r-project.org/web/packages/coda/index.html.

ROSA, G. J. M., C. R. PADOVANI and D. GIANOLA, 2003 Robust linear mixed models with normal/independent distributions and Bayesian MCMC implementation. Biom. J. 45: 573–590.[CrossRef]

ROSA, G. J. M., D. GIANOLA and C. R. PADOVANI, 2004 Bayesian longitudinal data analysis with mixed models and thick-tailed distributions using MCMC. J. Appl. Stat. 31: 855–873.[CrossRef]

SORENSEN, D., and D. GIANOLA, 2002 Likelihood, Bayesian, and MCMC Methods in Quantitative Genetics. Springer, New York.

STRANDÉN, I., and D. GIANOLA, 1998 Attenuating effects of preferential treatment with Student-t mixed linear models: a simulation study. Genet. Sel. Evol. 30: 565–583.[CrossRef]

TURELLI, M., 1985 Effects of pleiotropy on predictions concerning mutation selection balance for polygenic traits. Genetics 111: 165–195.[Abstract/Free Full Text]

VAN RADEN, P. M., 2008 Efficient methods to compute genomic predictions. J. Dairy Sci. 91: 4414–4423.[CrossRef][Medline]

VAN RADEN, P. M., C. P. VAN TASSELL, G. R. WIGGANS, T. S. SONSTEGARD, R. D. SCHNABEL et al., 2009 Reliability of genomic predictions for North American Holstein bulls. J. Dairy Sci. 92: 16–24.[CrossRef][Medline]

WANG, C. S., J. J. RUTLEDGE and D. GIANOLA, 1993 Marginal inferences about variance components in a mixed linear model using Gibbs sampling. Genet. Sel. Evol. 25: 41–62.[CrossRef]

WANG, C. S., J. J. RUTLEDGE and D. GIANOLA, 1994 Bayesian analysis of mixed linear models via Gibbs sampling with an application to litter size in Iberian pigs. Genet. Sel. Evol. 26: 91–115.[CrossRef]

WHITTAKER, J. C., R. THOMPSON and M. C. DENHAM, 2000 Marker-assisted selection using ridge regression. Genet. Res. 75: 249–252.[CrossRef][Medline]

WRIGHT, S., 1937 The distribution of gene frequencies in populations. Proc. Natl. Acad. Sci. USA 23: 307–320.[Free Full Text]

YI, N., and S. XU, 2008 Bayesian Lasso for quantitative trait loci mapping. Genetics 179: 1045–1055.[Abstract/Free Full Text]

XU, S., 2003 Estimating polygenic effects using markers of the entire genome. Genetics 163: 789–801.[Abstract/Free Full Text]

ZHANG, X. S., and W. G. HILL, 2005 Predictions of patterns of response to artificial selection in lines derived from natural populations. Genetics 169: 411–425.[Abstract/Free Full Text]

Communicating editor: E. ARJAS




This article has been cited by other articles:


Home page
GeneticsHome page
H. D. Daetwyler, R. Pong-Wong, B. Villanueva, and J. A. Woolliams
The Impact of Genetic Architecture on Genome-Wide Evaluation Methods
Genetics, July 1, 2010; 185(3): 1021 - 1031.
[Abstract] [Full Text] [PDF]